Patent: 9,867,806
✉ Email this page to a colleague
Summary for Patent: 9,867,806
Title: | Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis |
Abstract: | The present invention discloses compounds according to Formula I: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, L, and the subscript m are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions, and methods of treatment using the same, for the treatment of cystic fibrosis by administering a compound of the invention. |
Inventor(s): | De Blieck; Ann (Mechelen, BE), De Munck; Tom Roger Lisette (Mechelen, BE), Joannesse; Caroline Martine Andre (Mechelen, BE), Kelgtermans; Hans (Mechelen, BE), Mammoliti; Oscar (Mechelen, BE), Menet; Christel Jeanne Marie (Mechelen, BE), Tricarico; Giovanni Alessandro (Mechelen, BE), Van der Plas; Steven Emiel (Mechelen, BE) |
Assignee: | Galapagos NV (Mechelen, BE) |
Application Number: | 15/160,639 |
Patent Claims: | see list of patent claims |
Details for Patent 9,867,806
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | COTAZYM | pancrelipase | Capsule, Delayed Release | 020580 | 12/09/1996 | ⤷ Try a Trial | 2033-05-07 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 04/30/2009 | ⤷ Try a Trial | 2033-05-07 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 06/10/2011 | ⤷ Try a Trial | 2033-05-07 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 03/14/2013 | ⤷ Try a Trial | 2033-05-07 |
Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | 05/17/2012 | ⤷ Try a Trial | 2033-05-07 |
Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | 10/06/2016 | ⤷ Try a Trial | 2033-05-07 |
Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | 07/13/2017 | ⤷ Try a Trial | 2033-05-07 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |